Submitted by Anonymous (not verified) on 14 October 2026 - 10:35
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 7, Status: Authorised